Innovation in hematology. Perspectives: CML 2016

por Hehlmann, Rüdiger
Publicado no Haematologica (2016)

Research in the heart of hematology: chronic myeloid leukemia 2017

por Hehlmann, Rüdiger
Publicado no Haematologica (2017)

Chronic Myeloid Leukemia in 2020

por Hehlmann, Rüdiger
Publicado no Hemasphere (2020)

The New ELN Recommendations for Treating CML

por Hehlmann, Rüdiger
Publicado no J Clin Med (2020)

Genomic Instability in Context of the Chromosomal Theory

por Fabarius, Alice, Duesberg, Peter, Giehl, Michelle, Seifarth, Wolfgang, Hochhaus, Andreas, Hehlmann, Rüdiger
Publicado no Cell Oncol (2008)

Human Endogenous Retrovirus Expression Profiles in Samples from Brains of Patients with Schizophrenia and Bipolar Disorders

por Frank, Oliver, Giehl, Michelle, Zheng, Chun, Hehlmann, Rüdiger, Leib-Mösch, Christine, Seifarth, Wolfgang
Publicado em 2005

Rolf Neth (October 6, 1926 to March 17, 2020)

por Hehlmann, Rüdiger, Gallo, Robert, Hoelzer, Dieter, Welte, Karl, Gale, Robert Peter, Zander, Axel
Publicado no Leukemia (2020)

Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cells

por Krämer, Alwin, Hörner, Susanne, Willer, Andreas, Fruehauf, Stefan, Hochhaus, Andreas, Hallek, Michael, Hehlmann, Rüdiger
Publicado em 1999

Specific Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples of Immunocompromised Patients by Two-Step PCR

por Skladny, Heyko, Buchheidt, Dieter, Baust, Corinna, Krieg-Schneider, Frank, Seifarth, Wolfgang, Leib-Mösch, Christine, Hehlmann, Rüdiger
Publicado em 1999

Comprehensive Analysis of Human Endogenous Retrovirus Transcriptional Activity in Human Tissues with a Retrovirus-Specific Microarray

por Seifarth, Wolfgang, Frank, Oliver, Zeilfelder, Udo, Spiess, Birgit, Greenwood, Alex D., Hehlmann, Rüdiger, Leib-Mösch, Christine
Publicado em 2005

Variable Transcriptional Activity of Endogenous Retroviruses in Human Breast Cancer

por Frank, Oliver, Verbeke, Caroline, Schwarz, Norbert, Mayer, Jens, Fabarius, Alice, Hehlmann, Rüdiger, Leib-Mösch, Christine, Seifarth, Wolfgang
Publicado em 2008

DNA Microarray-Based Detection and Identification of Fungal Pathogens in Clinical Samples from Neutropenic Patients

por Spiess, Birgit, Seifarth, Wolfgang, Hummel, Margit, Frank, Oliver, Fabarius, Alice, Zheng, Chun, Mörz, Handan, Hehlmann, Rüdiger, Buchheidt, Dieter
Publicado em 2007

Development of a LightCycler PCR Assay for Detection and Quantification of Aspergillus fumigatus DNA in Clinical Samples from Neutropenic Patients

por Spiess, Birgit, Buchheidt, Dieter, Baust, Corinna, Skladny, Heyko, Seifarth, Wolfgang, Zeilfelder, Udo, Leib-Mösch, Christine, Mörz, Handan, Hehlmann, Rüdiger
Publicado em 2003

Proviral Structure, Chromosomal Location, and Expression of HERV-K-T47D, a Novel Human Endogenous Retrovirus Derived from T47D Particles

por Seifarth, Wolfgang, Baust, Corinna, Murr, Andreas, Skladny, Heyko, Krieg-Schneider, Frank, Blusch, Jürgen, Werner, Thomas, Hehlmann, Rüdiger, Leib-Mösch, Christine
Publicado em 1998

A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α

por Kreil, Sebastian, Waghorn, Katherine, Ernst, Thomas, Chase, Andrew, White, Helen, Hehlmann, Rüdiger, Reiter, Andreas, Hochhaus, Andreas, Cross, Nicholas C.P.
Publicado em 2010

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy

por Hanfstein, Benjamin, Müller, Martin C., Kreil, Sebastian, Ernst, Thomas, Schenk, Thomas, Lorentz, Christian, Schwindel, Uwe, Leitner, Armin, Hehlmann, Rüdiger, Hochhaus, Andreas
Publicado em 2011

Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic‐phase CML in clinical practice: 3‐year European SIMPLICITY data

por Gambacorti‐Passerini, Carlo, Chen, Clara, Davis, Catherine, Sen, Ginny P., Guyan, Christy, Hehlmann, Rüdiger, Michallet, Mauricette, Paquette, Ronald, Goldberg, Stuart L.
Publicado no Eur J Haematol (2020)

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

por Padula, William V., Larson, Richard A., Dusetzina, Stacie B., Apperley, Jane F., Hehlmann, Rudiger, Baccarani, Michele, Eigendorff, Ekkehard, Guilhot, Joelle, Guilhot, Francois, Hehlmann, Rudiger, Mahon, Francois-Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C., Niederwieser, Dietger, Saussele, Susanne, Schiffer, Charles A., Silver, Richard T., Simonsson, Bengt, Conti, Rena M.
Publicado no J Natl Cancer Inst (2016)

Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy

por Haaß, Wiltrud, Kleiner, Helga, Weiß, Christel, Haferlach, Claudia, Schlegelberger, Brigitte, Müller, Martin C., Hehlmann, Rüdiger, Hofmann, Wolf-Karsten, Fabarius, Alice, Seifarth, Wolfgang
Publicado no PLoS One (2015)

Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms

por Mughal, Tariq I., Abdel-Wahab, Omar, Rampal, Raajit, Mesa, Ruben, Koschmieder, Steffen, Levine, Ross, Hehlmann, Rüdiger, Saglio, Giuseppe, Barbui, Tiziano, Van Etten, Richard A.
Publicado no Leuk Lymphoma (2016)